Literature DB >> 1387116

Doxazosin in the management of hypertensive diabetes--a cautionary note (?).

B McLaughlin1, L Daly, J G Devlin.   

Abstract

Twenty-two patients with diabetes and hypertension were treated with Doxazosin. An acceptable fall in blood pressure was found with 1 mg. in 50% of patients and 2-8 mgs. in 50%. An increase in HDL cholesterol and a fall in LDL cholesterol levels which reached statistical significance was observed. A small but significant increase in HBA1 levels occurred in the 50% of patients on the higher Doxazosin dose.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387116     DOI: 10.1007/bf02984668

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  13 in total

Review 1.  Lipids, diabetes, and vascular disease: the time to act.

Authors:  D J Betteridge
Journal:  Diabet Med       Date:  1989-04       Impact factor: 4.359

2.  A single-blind study of doxazosin in the treatment of mild-to-moderate essential hypertensive patients with concomitant noninsulin-dependent diabetes mellitus.

Authors:  R Castrignano; A D'Angelo; T Pati; M Al Awady; R Tronca; G Crepaldi
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

3.  Plasma triglyceride levels and coronary disease.

Authors:  J D Brunzell; M A Austin
Journal:  N Engl J Med       Date:  1989-05-11       Impact factor: 91.245

4.  Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension.

Authors:  L X Cubeddu; J L Pool; R Bloomfield; P E Klotman; B I Pickering; D G Wombolt; E B Nelson; A Halperin
Journal:  Am J Hypertens       Date:  1988-04       Impact factor: 2.689

5.  Consensus conference. Lowering blood cholesterol to prevent heart disease.

Authors: 
Journal:  JAMA       Date:  1985-04-12       Impact factor: 56.272

6.  Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

7.  Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.

Authors: 
Journal:  Eur Heart J       Date:  1987-01       Impact factor: 29.983

8.  Diabetes and cardiovascular disease. The Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  JAMA       Date:  1979-05-11       Impact factor: 56.272

9.  Effect of alpha-1-blockade by prazosin on blood sugar, insulin and glucagon levels in normals and non-insulin dependent diabetics.

Authors:  S Ferlito; F Puleo; G Carrà; G Damante; S Di Vincenzo; F Del Campo
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

10.  Metabolic effects of chronic prazosin treatment.

Authors:  C Barbieri; C Ferrari; M Borzio; V Piepoli; R Caldara
Journal:  Horm Metab Res       Date:  1980-07       Impact factor: 2.936

View more
  1 in total

Review 1.  Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia.

Authors:  B Fulton; A J Wagstaff; E M Sorkin
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.